Search

Thanks to everyone who attended two exciting forums we helped co-host this week! Yesterday we had 'Phage Therapy UK: Moving toward clinical trials', which brought tons of fruitful conversations among phage-interested medical professionals,

Phico Therapeutics was awarded up to 18.2M from CARB-X to pursue phase I clinical trials using its engineered phage-based platform, SASPject™.

Felix Biotechnology, alongside researchers at Yale University (including labs of Paul Turner, Ben Chan and Jon Koff), are recruiting patients for a cystic fibrosis phage therapy clinical trial! If interested, please contact claire.cochrane@

Prisca Perlemoine (University Grenoble Alpes, France) and colleagues published a new paper in PLOS ONE on phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth.

Dimitrios Skliros (Agricultural University of Athens, Greece) and colleagues published a new paper in Viruses describing how the development of phage resistance in Vibrio alginolyticus depends on a complex metabolic adaptation strategy.

Martin Loessner and Rob Lavigne co-edited a special issue of Current Opinion in Biotechnology dedicated to phage, entitled Nanobiotechnology — Phage Therapy. The issue is now complete: check out the 21 articles here!

Phil Huss (University of Wisconsin-Madison) and colleagues published a new paper in eLife describing their use of deep mutational scanning to map the functional landscape of the T7 phage receptor binding domain. Using this high-throughput,

Janet Nale and Martha Clokie (University of Leicester) published a new perspective in Current Opinion in Biotechnology on preclinical data and safety assessment of phage therapy in humans. They emphasize that safety and efficacy data is nee

One issue that obstructs phage efficiency in vivo is poor localization of phage to the site of infection. Aurelija Grigonyte (University of Warwick) and colleagues published a new paper in Pharmaceuticals showing how they modified phages to

Several high-profile phage therapy clinical trials have failed, leading many to point toward phage formulation and method of application as being of underappreciated importance. Daniel Rosner (Fixed Phage, Glasgow) and colleagues published

Ellina Trofimova (Macquarie University, Australia) and colleagues published a new preprint describing Plaque Size Tool: an automated command-line application for plaque analysis, which can simplify and standardize phage plaque morphology me

The Africa Phage Forum is hosting its next phage webinar in its series, April 23 at 4pm GMT with special guest Dr. Jesca Nakavuma (Veterinarian and Senior Lecturer at Makerere University, Uganda), who will give a talk entitled Practical cha

Thanks to everyone who attended one or both of the PHAVES events we hosted this week! We heard Dr. Clara Torres-Barceló talk about phages for plant pathogens (recording here!), and Dr. Randy Fish talk about phages for diabetic foot infectio

Today, like all Fridays these days, it's 'Phage Phridays' in the 'Phage Club' on Clubhouse!. Time: 4PM Central (new time this week!) Theme: CRISPR and anti-CRISPR! Special guest: Joe Bondy-Denomy Hosts: Adriana Carolina Hernandez, Sabrina G

Hello everyone! My name is Melissa and I am a 3rd year grad student in the Biology department at the University of Alabama at Birmingham researching the mechanics of phage evolution. I am seeking obligately lytic phages that target Pseudomo

Check out this YouTube explainer video by Dr. Sabrina Green, R&D Director at BCM Tailor Labs, entitled 'Developing an Expedited Pipeline to Develop Phage Therapy for Multidrug-Resistant Infections'. Subscribe to their channel here for lots

Today, like all Fridays these days, it's 'Phage Phridays' in the 'Phage Club' on Clubhouse!. Time: 4PM Central (new time this week!) Theme: CRISPR and anti-CRISPR! Special guest: Joe Bondy-Denomy Hosts: Adriana Carolina Hernandez, Sabrina G

We are excited to announce that we are holding a forum on Phage Therapy in the United Kingdom on the 22nd of April, 2pm-6pm BST. This event will be focussed on planning the pathway to phage therapy in UK, starting with testing phage therap

UCSD's phage therapy center, IPATH, released its latest quarterly newsletter! It features an interview with David Pride, with questions like 'what is a phage library', 'how could a phage library benefit patients', and more! It also features

Phage Club on Clubhouse (a new audio-only chat app) is back next week on Wednesday night (9PM Eastern). Also, Sabrina Green and Adriana Carolina Hernandez Morales have been hosting Phage Club rooms on Fridays (Phage Phridays!) at 1PM Centr